How is the Halozyme Therapeutics Inc. today?

The Halozyme Therapeutics Inc. today is trading in the green, up by 4.37% at 60.22.

Halozyme Therapeutics Inc. XNAS: HALO

Halozyme Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Halozyme Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Halozyme Therapeutics Inc.
Rating: 3.054749875
Author: Trendlyne DVM scores

Expensive Performer

Download real time

60.22 2.52 (4.37%)

59.61% Gain from 52W Low

1.8M XNAS Volume

XNAS 11 Apr, 2025 5:30 PM (EDT)

High Financial Strength

83.3 / 100

Expensive Valuation

28.3 / 100

Technically Neutral

49.4 / 100

Expensive Performer These stocks are strong in quality but with mid-range technical aspects. Their strong financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

68

1Yr Price target upside is 13%

8 analysts

Halozyme Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Halozyme Therapeutics Inc. FAQ

How is Halozyme Therapeutics Inc. today?

Halozyme Therapeutics Inc. today is trading in the green, and is up by 4.37% at 60.22.

How has Halozyme Therapeutics Inc. performed historically?

Halozyme Therapeutics Inc. is currently trading up 4.37% on an intraday basis. In the past week the stock rose 0.75%. stock has been up 11.23% in the past quarter and rose 55.97% in the past year. You can view this in the overview section.